# Strengthening the competitiveness of EU in vitro biotechnologies

## TL;DR

The EU leads in developing in vitro biotechnology but faces challenges in turning these innovations into successful businesses.

## Contribution

This paper highlights the EU's struggle to translate IVB research into market competitiveness.

## Key findings

- The EU leads in IVB research and development.
- The EU struggles to convert IVB discoveries into business creation.
- The international IVB market is rapidly growing.

## Abstract

The EU has been a leader in research and development of in vitro biotechnology (IVB), such as human 3D cell and tissue models used in disease research and drug development. However, it is struggling to convert scientific discoveries into business creation and competitiveness within a rapidly growing international market.

The EU has been a leader in research and development of in vitro biotechnology (IVB), such as human 3D cell and tissue models used in disease research and drug development. However, it is struggling to convert scientific discoveries into business creation and competitiveness within a rapidly growing international market.